FDA recall record

Hikari Enjuku Koji Miso Mutenka recall — FDA F-1189-2019

Miso product manufactured in Japan was distributed in US with no English labeling and therefore soy beans not properly declared on label as an allergen.

Class IIIclassification
F-1189-2019official record ID
Mar 20, 2019report date

Recall record at a glance

Official recordF-1189-2019
CategoryFood Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmHikari Miso International, Inc.
Report dateMar 20, 2019
Recall initiation dateFeb 1, 2019
Quantity224 cases ( 8 tubs per case)
LocationTorrance, CA, United States

Official product description

Hikari Enjuku Koji Miso Mutenka; 26.6 oz. plastic tub with lid. UPC 4 905663 003007

Why the product was recalled

Miso product manufactured in Japan was distributed in US with no English labeling and therefore soy beans not properly declared on label as an allergen.

Distribution information

One distributor in CA only

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.